Cerenome Capital Expenditures (CapEx) Growth & History (CNSY)
Cerenome's capital expenditures (capex) was $67,000 for fiscal 2025.
View full Cerenome company overviewCerenome annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $67,000 | −$79,000 | −54.11% |
| 2024 | 2024-12-31 | $146,000 | −$14,000 | −8.75% |
| 2023 | 2023-12-31 | $160,000 | −$599,000 | −78.92% |
| 2022 | 2022-12-31 | $759,000 | $759,000 | — |
| 2021 | 2021-12-31 | $0 | −$400,000 | — |
| 2020 | 2020-12-31 | $400,000 | $333,000 | +497.01% |
| 2019 | 2019-12-31 | $67,000 | −$66,000 | −49.62% |
| 2018 | 2018-12-31 | $133,000 | −$162,000 | −54.92% |
| 2017 | 2017-12-31 | $295,000 | $228,000 | +340.30% |
| 2016 | 2016-12-31 | $67,000 | −$544,000 | −89.03% |
| 2015 | 2015-12-31 | $611,000 | −$153,000 | −20.03% |
| 2014 | 2014-12-31 | $764,000 | $245,000 | +47.21% |
| 2013 | 2013-12-31 | $519,000 | −$685,000 | −56.89% |
| 2012 | 2012-12-31 | $1.2M | $644,000 | +115.00% |
| 2011 | 2011-12-31 | $560,000 | −$50,000 | −8.20% |
| 2010 | 2010-12-31 | $610,000 | $389,000 | +176.02% |
| 2009 | 2009-12-31 | $221,000 | — | — |
Cerenome quarterly capital expenditures (capex)
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $499,000 | $492,000 | +7028.57% |
| Q1 2026 | 2026-03-31 | $818,000 | $815,000 | +27166.67% |
| Q4 2025 | 2025-12-31 | $30,000 | $19,000 | +172.73% |
| Q3 2025 | 2025-09-30 | $27,000 | $13,000 | +92.86% |
| Q2 2025 | 2025-06-30 | $7,000 | −$74,000 | −91.36% |
| Q1 2025 | 2025-03-31 | $3,000 | −$37,000 | −92.50% |
| Q4 2024 | 2024-12-31 | $11,000 | −$31,000 | −73.81% |
| Q3 2024 | 2024-09-30 | $14,000 | $4,000 | +40.00% |
| Q2 2024 | 2024-06-30 | $81,000 | $70,000 | +636.36% |
| Q1 2024 | 2024-03-31 | $40,000 | −$57,000 | −58.76% |
| Q4 2023 | 2023-12-31 | $42,000 | — | — |
| Q3 2023 | 2023-09-30 | $10,000 | −$23,000 | −69.70% |
| Q2 2023 | 2023-06-30 | $11,000 | −$127,000 | −92.03% |
| Q1 2023 | 2023-03-31 | $97,000 | −$113,000 | −53.81% |
| Q3 2022 | 2022-09-30 | $33,000 | −$21,000 | −38.89% |
| Q2 2022 | 2022-06-30 | $138,000 | $134,000 | +3350.00% |
| Q1 2022 | 2022-03-31 | $210,000 | $126,000 | +150.00% |
| Q4 2021 | 2021-12-31 | $134,000 | −$229,000 | −63.09% |
| Q3 2021 | 2021-09-30 | $54,000 | $40,000 | +285.71% |
| Q2 2021 | 2021-06-30 | $4,000 | −$8,000 | −66.67% |
| Q1 2021 | 2021-03-31 | $84,000 | $73,000 | +663.64% |
| Q4 2020 | 2020-12-31 | $363,000 | $304,000 | +515.25% |
| Q3 2020 | 2020-09-30 | $14,000 | $12,000 | +600.00% |
| Q2 2020 | 2020-06-30 | $12,000 | $12,000 | — |
| Q1 2020 | 2020-03-31 | $11,000 | $5,000 | +83.33% |
| Q4 2019 | 2019-12-31 | $59,000 | $54,000 | +1080.00% |
| Q3 2019 | 2019-09-30 | $2,000 | −$48,000 | −96.00% |
| Q2 2019 | 2019-06-30 | $0 | −$25,000 | — |
| Q1 2019 | 2019-03-31 | $6,000 | −$47,000 | −88.68% |
| Q4 2018 | 2018-12-31 | $5,000 | −$19,000 | −79.17% |
| Q3 2018 | 2018-09-30 | $50,000 | −$126,000 | −71.59% |
| Q2 2018 | 2018-06-30 | $25,000 | −$65,000 | −72.22% |
| Q1 2018 | 2018-03-31 | $53,000 | $48,000 | +960.00% |
| Q4 2017 | 2017-12-31 | $24,000 | −$19,000 | −44.19% |
| Q3 2017 | 2017-09-30 | $176,000 | $171,000 | +3420.00% |
| Q2 2017 | 2017-06-30 | $90,000 | $54,000 | +150.00% |
| Q1 2017 | 2017-03-31 | $5,000 | −$64,000 | −92.75% |
| Q4 2016 | 2016-12-31 | $43,000 | −$24,000 | −35.82% |
| Q3 2016 | 2016-09-30 | $5,000 | −$42,000 | −89.36% |
| Q2 2016 | 2016-06-30 | $36,000 | −$274,000 | −88.39% |
| Q1 2016 | 2016-03-31 | $69,000 | −$118,000 | −63.10% |
| Q4 2015 | 2015-12-31 | $67,000 | $39,000 | +139.29% |
| Q3 2015 | 2015-09-30 | $47,000 | −$278,000 | −85.54% |
| Q2 2015 | 2015-06-30 | $310,000 | $130,000 | +72.22% |
| Q1 2015 | 2015-03-31 | $187,000 | −$100,000 | −34.84% |
| Q4 2014 | 2014-12-31 | $28,000 | $11,000 | +64.71% |
| Q3 2014 | 2014-09-30 | $325,000 | $221,000 | +212.50% |
| Q2 2014 | 2014-06-30 | $180,000 | −$171,000 | −48.72% |
| Q1 2014 | 2014-03-31 | $287,000 | $206,000 | +254.32% |
| Q4 2013 | 2013-12-31 | $17,000 | −$110,000 | −86.61% |
| Q3 2013 | 2013-09-30 | $104,000 | −$87,000 | −45.55% |
| Q2 2013 | 2013-06-30 | $351,000 | −$510,000 | −59.23% |
| Q1 2013 | 2013-03-31 | $81,000 | $56,000 | +224.00% |
| Q4 2012 | 2012-12-31 | $127,000 | $25,000 | +24.51% |
| Q3 2012 | 2012-09-30 | $191,000 | $166,000 | +664.00% |
| Q2 2012 | 2012-06-30 | $861,000 | $559,000 | +185.10% |
| Q1 2012 | 2012-03-31 | $25,000 | −$106,000 | −80.92% |
| Q4 2011 | 2011-12-31 | $102,000 | — | — |
| Q3 2011 | 2011-09-30 | $25,000 | −$100,000 | −80.00% |
| Q2 2011 | 2011-06-30 | $302,000 | — | — |
| Q1 2011 | 2011-03-31 | $131,000 | — | — |
| Q3 2010 | 2010-09-30 | $125,000 | — | — |
Cerenome capital expenditures (capex) trends
Over the last five fiscal years, Cerenome's capital expenditures (capex) decreased from $400,000 to $67,000, a change of −$333,000. The latest reported quarter, Q2 2026, shows $499,000.
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Cerenome source filings ↗